Conclusion: These results suggest that fluvastatin reduces high glucose-induced NF-kappaB activation via the p38MAPK pathway in renal tubular epithelial cells in vivo and in vitro. The effect is at least partly due to blocking the biosynthesis of mevalonate.
PMID: 22641573 [PubMed - as supplied by publisher] (Source: Journal of Nephrology)